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Introduction
Osteoarthritis (OA) is the most common arthritic condition, clinically characterized by articular cartilage 
degeneration, subchondral bone sclerosis, synovitis, and osteophyte formation (1). OA risk factors include 
age, gender, obesity, prior joint injury, mechanics (e.g., joint malalignment), and inherent genetic altera-
tions (1, 2). Currently, there are still no effective disease-modifying treatments for OA except pain relief  
medication and surgical replacement of  damaged joints (3–5).
At the tissue level, disruption of cartilage homeostasis in OA results in enhanced catabolism and subse-
quent extracellular matrix (ECM) degradation. Many of the cellular and molecular changes in OA have been 
identified in studies utilizing murine models of OA or from analysis of human cartilage/chondrocytes from 
OA patients (6–8). As a result, there is the potential for development of new therapeutic approaches to target 
factors involved in inflammation, oxidative stress, and autophagy, to name a few (9). In addition to altered cel-
lular and molecular pathways, a number of gene polymorphisms have been reported in human OA (e.g., GDF5 
and SMAD3) (10, 11) and there are now several, robustly replicated, significant OA loci that have been identi-
fied by large-scale genome wide association studies (GWAS) (12–14). However, many candidate gene studies 
for OA have identified false associations due to relatively small sample sizes. For example, one study carried 
out meta-analysis from 9 GWAS and showed that only 2 out of 199 potential candidate genes (COL11A1 and 
VEGF) were associated with OA in human patients (15). The OA loci discovered to date explain only a small 
fraction of the heritability of OA estimated by epidemiological studies. It is now becoming clear that some of  
the missing heritability may be explained by inheritance of epigenetic modifications of genomic DNA (16–18).
DNA methylation is a well-characterized epigenetic mechanism involving the addition of  a methyl 
group (CH3) from the methyl donor S-adenosyl methionine (SAM) to a cytosine within CpG sites to form 
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5-methylcytosine (5mC). Methylation within promoters, enhancers, or gene bodies can significantly alter 
gene expression profiles (19, 20). Of  the 3 catalytic DNA methyltransferase enzymes, DNMT3A and 
DNMT3B are known as the de novo methyltransferases and are predominantly responsible for the estab-
lishment of  unique methylation patterns during development (21). DNMT1, however, is largely respon-
sible for maintaining the DNA methylation signatures created by these de novo enzymes during cell divi-
sion. Recent genome-wide methylation profiling studies have identified differentially methylated loci in the 
genome of  human OA chondrocytes, thereby suggesting the involvement of  DNMT-driven mechanisms in 
the development and/or progression of  OA (18, 22–26). This study was designed to address the potential 
role of  the de novo Dnmt3 enzymes in regulating murine articular cartilage homeostasis. We show that 
Dnmt3b loss of  function is associated with an OA-like pathology in mice due, in part, to alterations in cellu-
lar catabolic and metabolic processes. Importantly, we also show reduced DNMT3B expression in human 
OA chondrocytes and that Dnmt3b gain-of-function mice are protected from developing OA. These findings 
may lead to the discovery of  novel therapeutic targets to treat OA.
Results
Decreased expression of  Dnmt3b is associated with a murine and human OA phenotype. To determine protein local-
ization of  the de novo Dnmt3 enzymes in murine articular cartilage, IHC staining was carried out on tis-
sue sections of  3-month-old WT murine knee joints. Expression of  Dnmt3a was undetectable in articular 
and growth plate cartilage (Figure 1A). However, Dnmt3b was abundantly expressed in chondrocytes of  
articular cartilage yet almost undetectable in chondrocytes of  the underlying growth plate (Figure 1A). 
During murine cartilage development, Dnmt3b was ubiquitously expressed in proliferating chondrocytes 
of  developing limbs at E18.5, while expression became restricted to articular chondrocytes during postnatal 
development (Supplemental Figure 1; supplemental material available online with this article; https://doi.
org/10.1172/jci.insight.93612DS1).
We next examined the effects of  aging and OA on Dnmt3b expression in cartilage. Analysis of  an 
age range of  articular cartilage tissue sections revealed a trend toward decreased Dnmt3b expression 
with increasing age as shown by 2 representative IHC images (at 3 and 27 months old) (Figure 1B). Sur-
gical induction of  OA in mice was carried out by meniscal ligament injury (MLI) (8) to destabilize the 
joint and induce articular cartilage degradation over time. Lower Dnmt3b expression levels were noted 
in articular chondrocytes 4 weeks following MLI compared with sham controls (Figure 1C). It has been 
reported that mice fed a high-fat diet (HFD) develop accelerated OA (27). Here we also show reduced 
expression of  Dnmt3b in chondrocytes from mice fed a HFD for 4 weeks compared with control mice 
fed a normal diet (Figure 1D).
In human nondiseased articular cartilage tissue sections, abundant DNMT3B expression was consis-
tently detected, whereas expression was either undetectable or restricted to articular chondrocytes of  the 
deep zone. However, DNMT3B expression in cells from OA tissues ranged from undetectable to some posi-
tively labeled cells in the deeper zones of  articular cartilage (Figure 1E). Decreased DNMT3B expression in 
OA cartilage was further confirmed by real-time quantitative PCR (qPCR) from human primary articular 
chondrocytes (PACs) (Figure 1F). Treatment of  human PACs with the proinflammatory cytokine IL-1β 
resulted in decreased DNMT3B mRNA and protein expression (Figure 1G). These PACs were obtained 
from knee joints following total knee replacement surgery and were found to be responsive to IL-1β based 
on the expected changes in COL2A1 and MMP-13 expression (Supplemental Figure 2). Similarly, Dnmt3b 
expression was also decreased in murine PACs in response to IL-1β (Supplemental Figure 3, E and F). 
These data suggest that inflammatory mediators (known to increase in the context of  OA) may regulate 
DNMT3B. In fact, we identified an NF-κB binding site in the promoter region of  the murine Dnmt3b 
gene (also present in the human DNMT3B promoter) (Supplemental Figure 3A). Luciferase reporter assays 
showed functional utilization of  the NF-κB binding site following IL-1β treatment of  murine ATDC-5 
cells; this affect was attenuated following mutation of  the binding site (Supplemental Figure 3B). NF-κB 
interaction with its binding site was also shown by ChIP assays (Supplemental Figure 3, C and D).
Given the trend toward decreased Dnmt3b expression with age and OA, the effect of  Dnmt3b knock-
down in murine PACs (Supplemental Figure 4, A and B) was examined. Knockdown resulted in decreased 
expression of  the anabolic cartilage gene Col2a1 and increased expression of  markers associated with catab-
olism or terminal hypertrophic chondrocyte differentiation (Col10a1, Runx2, and Mmp13) (Supplemental 
Figure 4C). Alkaline phosphatase (ALP) activity also increased in PACs following Dnmt3b knockdown, 
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Figure 1. Dnmt3b expression in murine and human knee joint cartilage. (A) Representative images showing that Dnmt3a is not expressed in chon-
drocytes from 3-month-old WT articular cartilage (Dnmt3a expression in pancreas served as a positive control), while robust expression of Dnmt3b is 
seen in chondrocytes of 3-month-old WT articular cartilage, with lower expression in underlying growth plate cartilage (n = 3); the magnified images 
of the dashed and solid boxed areas of articular cartilage are in separate panels. (B) Representative images showing Dnmt3b expression in 3-month-
old (n = 3) versus 27-month-old (n = 3) WT murine knee articular cartilage. (C) Representative images showing Dnmt3b expression in 14-week-old 
murine articular cartilage following meniscal ligament injury (MLI) surgery (n = 3) or cartilage from sham control knees (n = 3). (D) Representative 
images showing Dnmt3b expression in 14-week-old murine articular cartilage in mice fed a high-fat diet (HFD) (n = 3) or controls (Ctrl) fed a normal 
diet (n = 3). (E) Two representative images showing DNMT3B expression in human healthy (ND) articular cartilage (n = 11) or osteoarthritic (OA) car-
tilage tissue sections (n = 71). (F) Reduced DNMT3B expression in human primary OA chondrocytes compared with healthy chondrocytes (n = 3). (G) 
Induction of human primary chondrocytes (n = 3) with IL-1β results in decreased expression of DNMT3B mRNA and protein levels. Scale bars: 100 μm. 
*P < 0.05 by 2-tailed Student’s t test.
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albeit not to the level induced by BMP-2 (Supplemental Figure 4D). Since TGF-β and BMP signaling 
can have opposing effects on chondrocyte catabolism (2), Smad signaling was analyzed following Dnmt3b 
knockdown. Phospho-Smad2 (p-Smad2) levels decreased while p-Smad1/5 levels increased following 
Dnmt3b siRNA treatment (Supplemental Figure 4, E and F). This suggests that increased BMP-2 signaling 
may, in part, explain the increase in chondrocyte catabolism.
Dnmt3b conditional knockdown in vivo results in a progressive OA-like pathology. To investigate the effect of Dnmt3b 
knockdown in vivo, transgenic mice were generated to conditionally delete Dnmt3b in cartilage using the Cre-
driver line, AgcCreERT2 (28). The specificity of this Cre-driver line to target chondrocytes in cartilage tissue was 
confirmed by crossing with Rosa-tomato (mT/mG) mice (Supplemental Figure 5A). AgcCreERT2; Dnmt3bfl/fl mice 
Figure 2. Dnmt3b loss-of-function mice develop accelerated osteoarthritis. (A) Representative Alcian blue/hematoxylin/orange G (ABH/OG) staining of 
tissue sections of knee joints harvested from 5- and 8-month-old Dnmt3b loss-of-function (LOF) mice and Cre+ control (Ctrl) mice (n = 5). The magnified 
images of the boxed regions are shown in separate panels. (B) OARSI scoring system was used to quantify the ABH/OG–stained tissue sections (n = 5). (C) 
Articular cartilage area was quantified by histomorphometry (n = 5). (D) Representative microCT images of knee joints from 8-month-old Dnmt3b LOF and 
Ctrl mice (n = 5). (E) Subchondral bone volume and (F) subchondral bone trabecular connective density were calculated from the microCT images (n = 5). 
Arrows in 5-month-old Dnmt3b LOF mice show areas of proteoglycan loss and cartilage fibrillation. Arrows in 8-month-old Dnmt3b LOF mice show osteo-
phyte formation and an area of proteoglycan loss in articular cartilage. Yellow arrows in microCT images denote osteophyte formation. Scale bars: 100 μm. 
*P < 0.05 by ANOVA with post hoc test (B and C) or 2-tailed Student’s t test (E and F).
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were generated and injected with tamoxifen at 2 months of age to avoid the developmental defect. Tamoxifen-
treated AgcCreERT2; Dnmt3bfl/fl mice will hereafter be referred to as Dnmt3b loss-of-function (LOF) mice. Supple-
mental Figure 5B shows an apparent reduction in Dnmt3b protein expression in articular cartilage from Dnmt3b 
LOF mice at 3 months of age. We then investigated if  expression levels of the other Dnmt’s (Dnmt3a and Dnmt1) 
or the recently discovered ten-eleven translocation (TET) DNA demethylation enzymes changed in Dnmt3b 
LOF cartilage. No significant changes in Dnmt3a, Dnmt1, Tet1, Tet2, or Tet3 expression was found (Supplemental 
Figure 6A). However, a small but significant decrease in overall TET activity was found (Supplemental Figure 
6B). Further analysis of chondrocyte gene expression from 3-month-old Dnmt3b LOF mice revealed a significant 
reduction in Col2a1 expression and significant increases in Col10a1, Runx2, and Mmp13 expression (Supplemen-
tal Figure 6C).
Tissue sections from knee joints of  male Dnmt3b LOF mice and male Cre+ control littermates at 5 and 8 
months of  age were histologically assessed for signs of  pathology. Compared with Cre+ controls, knee joints 
from 5-month-old Dnmt3b LOF male mice showed features of  OA including loss of  proteoglycan staining in 
regions of  articular cartilage in addition to articular cartilage tears (Figure 2A). A significant increase in the 
number of  apoptotic cells, as determined by TUNEL staining, was found in 5-month-old Dnmt3b LOF artic-
ular cartilage (Supplemental Figure 7, A and B). In vitro analysis of  Dnmt3b LOF articular chondrocytes 
also showed an increase in levels of  reactive oxygen species (ROS) compared with control cells (Supplemen-
tal Figure 7C). At 8 months of  age, histological staining revealed distorted whole-joint structure, osteophyte 
formation at the margin of  the joint, as well as loss of  proteoglycan staining (Figure 2A). Quantification of  
cartilage pathology using the Osteoarthritis Research Society International (OARSI) scoring system was per-
formed by 2 blinded researchers by examining 13–16 slides per mice, and the results showed higher maximal 
scores for both 5- and 8-month-old Dnmt3b LOF knee joints compared with age-matched joints from Cre+ 
control mice (Figure 2B). Also, histomorphometric analysis showed a significant decrease in cartilage area 
in 5- and 8-month-old Dnmt3b LOF mice compared with age-matched Cre+ controls (Figure 2C). MicroCT 
analysis of  8-month-old knee joints showed the presence of  osteophytes (Figure 2D), and quantification of  
these scanned images showed an increase in subchondral bone thickness in 8-month-old Dnmt3b LOF mice 
compared with age-matched controls (Figure 2, E and F).
Transcriptomic and epigenomic alterations in Dnmt3b LOF chondrocytes. To investigate the mechanism by 
which loss of  Dnmt3b in articular chondrocytes led to articular chondrocyte hypertrophy and cartilage 
tissue degeneration, PACs were isolated from 2-month-old Dnmt3bfl/fl mice and infected with either Ad5-
CMV-Cre (Dnmt3b LOF cells, n = 3) or Ad5-CMV-GFP (control cells, n = 3) for 72 hours and followed 
by RNA-Seq and methylC-Seq (see Methods) analyses to examine genome wide gene transcription and 
DNA methylation alterations in LOF chondrocytes. Loss of  Dnmt3b was associated with subtle but pro-
found DNA methylation and gene expression changes in articular chondrocytes (Figure 3 and Supple-
mental Figure 8). Global gene expression exhibited systematic differences between Dnmt3b LOF and con-
trol, as illustrated by their separation pattern in principle component analysis (Figure 3A) and in pairwise 
clustering analysis (Supplemental Figure 8A). Overall, 368 genes were found to be significantly differen-
tially expressed (Supplemental Figure 8B); the hierarchical clustering pattern of  the top 25 differentially 
expressed genes is shown (Figure 3B). Network analysis of  the top 25 differentially expressed genes suggest 
they are coexpressed or colocalized (Supplemental Figure 8C). These 368 genes include members of  the 
BMP/TGF signaling pathways (e.g., Bmp4 and Tgfbr2) as well as those involved in catabolic/hypertrophic 
processes (e.g., Smad2/3, Runx2, and Mmp13) (Figure 3, B and C, Supplemental Figure 8D, and supple-
mental differentially expressed gene list). Overall, the RNA-Seq data showing alterations in BMP/TGF 
signaling and catabolic/hypertrophic genes is in agreement with changes known to occur in OA as well as 
our own in vitro and in vivo data presented here related to Dnmt3b LOF effects in vitro and in vivo. By gene 
ontology enrichment analysis and ingenuity pathway analysis (IPA), functions including cell cycle process, 
ossification, osteoblast development, lipid metabolism, cell death, and survival comprised the top hits for 
these differentially expressed genes (Tables 1 and 2). These functions were highly relevant to the morphol-
ogy of  bone and skeleton, as well as cartilage development.
The global DNA methylation pattern followed classic bimodal distribution and did not exhibit sig-
nificant differences between Dnmt3b LOF and control (Figure 3D). However, local differentially methyl-
ated regions (DMRs) were widespread. Overall 4,271 DMRs were identified, with a mean difference in 
methylation level of  32% (Figure 3, E and F, and supplemental DMR list). The large majority (97%) of  
these DMRs were located in introns and intergenic regions, with only 1% overlapping gene promoters 
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(Supplemental Figure 8E). Of  all the DMRs, 44% exhibited hypomethylation, and 56% hypermeth-
ylation. Using GREAT (29), DMRs were associated with nearby genes; these DMR-associated genes 
overlapped significantly with differentially expressed genes (P < 6 × 10–6), and they enriched for func-
tions related to osteoblasts and chondrocytes. One hundred and four genes exhibited changes in both 
expression and DNA methylation; two-thirds of  these were hypomethylated, including cartilage genes 
that are known to be altered in OA: Ucma (30), Bmp4, and Igf1 (Figure 3, B and C). In addition, bind-
ing sites of  transcription factors including Fkhr, Foxc1, Foxk1, Sox4, Sox9, and Nfatc2 were significantly 
Figure 3. Altered epigenomic and transcriptomic signatures in Dnmt3b LOF chondrocytes. Genomic DNA and RNA isolated from control and Dnmt3b 
loss-of-function (LOF) cells for RNA-Seq and methylC-Seq analysis (n = 3). (A) Principal component analysis (PCA) plot of samples based on RNA-Seq data. 
(B) Heatmap display of top 25 significantly differentially expressed genes between Dnmt3b LOF and control. (C) Word cloud representing gene frequency of 
enriched function categories from all differentially expressed genes. (D) Global methylation distribution of Dnmt3b LOF and control samples showing that 
there is no global difference. (E) Methylation difference of differentially methylated regions (DMRs) versus genome as background. (F) Significant overlap 
of genes near DMRs and differentially expressed genes. P values were calculated by the hypergeometric test.
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enriched in DMRs, highlighting functional connections with pathways related to chondrogenesis (Sox4 
and Sox9), inflammation (Nfatc2), and FOXO-related energy metabolism (Fkhr, Foxc1, and Foxk1) (Sup-
plemental Figure 8F).
Increased mitochondrial metabolism in Dnmt3b LOF chondrocytes. Since mitochondria are the major organ-
elles for lipid metabolism and energy metabolism, we investigated mitochondrial function within the con-
text of  Dnmt3b LOF. Basal and maximal mitochondrial respiration was higher in Dnmt3b LOF cells (Figure 
4A); these findings coincided with the expected alteration in anabolic and catabolic gene expression in 
LOF cells (Supplemental Figure 9). Given the alterations in mitochondrial function, levels of  the TCA 
cycle metabolites succinate and fumarate were investigated and found to be increased in Dnmt3b LOF cells 
compared with control cells (Figure 4B). Levels of  reduced coenzyme NADH, also generated by the TCA 
cycle and fed into the oxidative phosphorylation pathway, were increased in Dnmt3b LOF cells (Figure 4B). 
Since succinate production was increased in Dnmt3b LOF cells, we then examined whether increased suc-
cinate levels coincides with increased chondrocyte catabolism/hypertrophy. Addition of  succinate to WT 
murine PACs (Supplemental Figure 10A) resulted in increased basal and maximal respiration (Figure 4C), 
decreased Col2a1 expression, and an increase in the hypertrophic/catabolic chondrocyte markers Runx2 
and Mmp13 (Supplemental Figure 10B). We then showed that antimycin A and rotenone (inhibitors of  
mitochondrial respiration, Figure 4D) could attenuate the effects of  BMP-2–induced hypertrophy of  WT 
murine PACs (Supplemental Figure 11B). These inhibitors had no effect on cell proliferation or cell death 
(Supplemental Figure 11A). These data strongly suggest that mitochondrial metabolism alterations coin-
cide with chondrocyte hypertrophy and that decreased expression/function of  Dnmt3b alters metabolic 
processes in chondrocytes undergoing hypertrophy.
Dnmt3b overexpression in vivo attenuates OA progression and alters chondrocyte metabolism. Given our findings 
that Dnmt3b LOF in vitro and in vivo induces hypertrophic/catabolic effects in chondrocytes, we hypoth-
esized that conditional overexpression of  Dnmt3b in postnatal cartilage could have a chondroprotective 
effect following surgical induction of  OA. Supplemental Figure 12 shows the strategy used to generate 
the Col2a1-Cre; Rosa-rtTAfl/+; Dnmt3b-tg (Dnmt3b gain-of-function [GOF]) mice. In this model, addition of  
doxycycline (DOX) results in the expression of  Dnmt3b in Col2a1-expressing cells. Supplemental Figure 
13A shows the specificity of  the Col2a1-Cre driver line in targeting chondrocytes in articular cartilage of  
Col2a1Cre; Rosa-rtTAfl/+; H2BGFP mice, while Supplemental Figure 13B confirms Dnmt3b protein over-
expression in articular chondrocytes isolated from Dnmt3b GOF mice. Therefore, this model provides both 
cell-specific and temporal regulation of  Dnmt3b overexpression.
Following DOX administration to 10-week-old male Dnmt3b GOF mice and Cre+ control mice, 
MLI surgeries or sham control surgeries were carried out 24 hours later. Histological examination 
showed no difference in synovial joint architecture between 22-week-old Dnmt3b GOF mice and Cre+ 
Table 1. Function analysis from RNA-Seq
Associated Network Functions Score
Cell Death and Survival, Cellular Assembly and Organization, Cellular Compromise 38
Lipid Metabolism, Molecular Transport, Small Molecular Biochemistry 36
Cell Cycle, Cellular Assembly and Organization, DNA Replication, Recombination, and Repair 32
 
Table 2. Enriched-pathway analysis from RNA-Seq
Enriched pathway P value
Hepatic Fibrosis/Hepatic Stellate Cell Activation 1.88 × 10–9
Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis 2.87 × 10–7
Adipogenesis Pathway 3.73 × 10–5
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control littermates in sham-operated mice (Figure 5A). However, Dnmt3b GOF mice displayed a protec-
tive effect against injury-induced OA progression at 8 and 12 weeks after MLI surgery. In general, the 
apparent loss of  articular cartilage tissue induced by MLI was not observed in the Dnmt3b GOF mice; 
in fact, articular cartilage thickness was increased in the Dnmt3b GOF mice (Figure 5A). Quantification 
using the OARSI scoring system showed significantly lower maximal scores in the histological assess-
ment of  Dnmt3b GOF articular cartilage compared with controls at both 8 and 12 weeks (Figure 5B). 
Histomorphometric analyses also revealed a significant increase in articular cartilage area in Dnmt3b 
Figure 4. Mitochondrial function and cellular homeostasis in Dnmt3b LOF chondrocytes. Primary articular chondrocytes were isolated from 2-month-
old Dnmt3bfl/fl mice and infected with Ad5-Cre (Dnmt3b loss-of-function [LOF]) or Ad5-GFP (Ctrl) for 48 hours. (A) Mitochondrial respiration was mea-
sured by the Seahorse XF Extracellular Flux Analyzer. Basal respiration and maximal respiration, as measured by the oxygen consumption rate (OCR) are 
shown (n = 8). (B) TCA metabolite (succinate, fumarate) and NADH analysis by HPLC-MS (n = 3). (C) Mitochondrial metabolism analysis was measured in 
2-month-old WT cells treated with either 1 mM diethyl succinate or vehicle (Veh) for 48 hours by the Seahorse XF Extracellular Flux Analyzer (n = 8). (D) 
Mitochondrial respiration analysis in BMP-2–treated 2-month-old WT chondrocytes in the absence (Veh) or presence of antimycin A + rotenone (A&R) 
for 48 hours (n = 8). *P < 0.05 by 2-tailed Student’s t test.
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GOF mice compared with controls (Figure 5C). Articular chondrocytes isolated from Dnmt3b GOF 
mice confirmed that expression of  Col2a1 was significantly higher in Dnmt3b GOF cartilage, while 
expression of  the hypertrophic markers Runx2 and Mmp13 was reduced compared with control articular 
cartilage (Figure 6A).
To determine if  mitochondrial metabolism was altered in Dnmt3b GOF chondrocytes, PACs from 
Dnmt3b GOF mice or Cre+ control mice were treated with BMP-2 to induce hypertrophy. Following treat-
ment with BMP-2, we found that the basal and maximal respiration rates of  Dnmt3b GOF cells were sig-
nificantly lower than in control cells (Figure 6B). These data strongly suggest that modulation of  Dnmt3b 
levels within the context of  joint injury can alter mitochondrial metabolic processes to maintain articular 
chondrocyte homeostasis and attenuate the progression of  articular cartilage degradation.
Discussion
Recent genome-wide methylation profiling studies show that DMLs exist in DNA from OA chondrocytes 
compared with nondiseased control cells (18). In other studies, hypermethylation of  SOX9 and COL9A1 
promoters was identified in OA chondrocytes, which correlated with decreased expression of  these genes 
(31, 32). Promoters of  genes encoding metalloproteinases (MMP3, MMP9, MMP13, and ADAMTS4), cyto-
kines (IL1 and IL8), sclerostin (SOST), and leptin (LEP), were shown to contain demethylated CpG sites 
or hypomethylation patterns, which may explain why these genes are upregulated in OA (33). From these 
findings, it could be hypothesized that epigenetic mechanisms involving DNMTs are responsible for disrup-
tion of  chondrocyte homeostasis in OA.
Figure 5. Dnmt3b gain-of-
function mice are protected 
from cartilage degeneration 
following surgical induction 
of osteoarthritis. Meniscal 
ligament injury (MLI) or sham 
surgeries were performed on 
Dnmt3b gain-of-function (GOF) 
mice or Cre+ control (Ctrl) mice. 
(A) Alcian blue/hematoxylin/
orange G–stained sections of 
Ctrl or Dnmt3b GOF knee joints 
12 weeks following sham sur-
gery. Representative images of 
histological sections from Ctrl 
or Dnmt3b GOF mice at 8 or 12 
weeks following MLI surgery (n 
= 5). The magnified images of 
the boxed regions are shown in 
separate panels. (B) Quantifi-
cation of histological assess-
ment by OARSI scoring (n = 5). 
(C) Histomorphometric analysis 
of Ctrl or Dnmt3b GOF cartilage 
(n = 5). Scale bars: 100 μm. *P 
< 0.05 by ANOVA followed by 
post hoc test.
1 0insight.jci.org   https://doi.org/10.1172/jci.insight.93612
R E S E A R C H  A R T I C L E
This study focused on the de novo Dnmt’s, and consistent with previous studies (34), we found that 
mRNA levels of  Dnmt1 and Dnmt3a were ~200-fold higher than that of  Dnmt3b mRNA levels in murine 
and human articular chondrocytes. However, our studies show that Dnmt3b protein expression was much 
higher in cartilage tissues when compared with Dnmt3a protein. The mechanism to explain these discrepan-
cies in mRNA and protein levels needs to be further investigated. Importantly, we showed that decreased 
Dnmt3b expression is associated with aging and osteoarthritic murine and human articular cartilage. To 
further explore the effects of  decreased Dnmt3b levels at the cell and tissue level, an LOF approach was 
pursued in vitro and in vivo. Interestingly, Dnmt3b LOF appeared to enhance expression of  markers associ-
ated with chondrocyte catabolism and terminal hypertrophic differentiation (Mmp13, Runx2, Col10a1, and 
Alp) and alter the balance of  BMP and TGF-β signaling, favoring the BMP pathway. These cellular changes 
are well known to occur in chondrocytes from cartilage at various stages of  OA (35). In agreement with 
these findings, conditional knockdown of  Dnmt3b in murine cartilage in vivo was found to result in acceler-
ated OA-like changes including cartilage fibrillation, osteophyte formation, increased ROS, and increased 
apoptosis. Importantly, overexpression of  Dnmt3b in murine articular cartilage following surgical induction 
of  OA appeared to be chondroprotective. Collectively, our data provide strong evidence that Dnmt3b-driven 
epigenetic mechanisms can regulate homeostasis of  mature articular cartilage tissue.
Chronic inflammation is thought to contribute to age-related diseases such as OA (36, 37). Our stud-
ies show that the proinflammatory cytokine IL-1β downregulates Dnmt3b in murine and human chon-
drocytes and that these effects may be mediated via NF-κB. Whether canonical and/or noncanonical 
NF-κB signaling mechanisms play a role in regulating Dnmt3b expression has yet to be determined. In 
addition, IL-1β has also been shown to downregulate TET1 in chondrocytes (38, 39). TET1 belongs to 
the TET family of  proteins that catalyze DNA demethylation, and there is growing interest in how these 
TET-mediated epigenetic processes control cartilage homeostasis. Recent studies have shown that TET 
proteins can inhibit inflammatory signals in other systems (40, 41). It will be interesting to elucidate if  the 
chondroprotective effects of  Dnmt3b may be due, in part, to attenuating inflammatory processes.
In addition to the expected changes in catabolic and hypertrophic gene expression due to Dnmt3b LOF, 
in-depth bioinformatics analyses of  RNA-Seq and methylC-Seq data provided insights into other genes 
and pathways that may also be affected. Interestingly, analysis of  differentially expressed genes in Dnmt3b 
LOF chondrocytes showed an enrichment in pathways involved in lipid metabolism. Lipids are important 
Figure 6. Mitochondrial function and cellular homeostasis in Dnmt3b GOF chondrocytes. (A) Gene expression in chondrocytes isolated from 10-week-
old Ctrl or Dnmt3b gain-of-function (GOF) mice (n = 3). (B) Mitochondrial respiration, as measured by the oxygen consumption rate (OCR), in primary 
articular chondrocytes isolated from 2-month-old Col2a1Cre; Rosa-rtTAfl/+; Dnmt3b-tg mice, treated with vehicle (Ctrl) or doxycycline (Dnmt3b GOF) for 
48 hours (n = 3). Mitochondrial respiration was measured by the Seahorse XF Extracellular Flux Analyzer. *P < 0.05 by 2-tailed Student’s t test.
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nutrients in chondrocyte metabolism and reports have shown a potential link between OA and disruptions 
in lipid metabolic processes (42–44). MethylC-Seq analysis also identified a number of  transcription factor 
binding sites that were enriched in DMRs in Dnmt3b LOF cells. Among these were binding sites for Fhkr, 
Foxc1, and Foxk1, which are known to be involved in regulating a number of  metabolic processes (45–47). 
Future studies in our laboratory are focused on identifying downstream metabolic targets of  Dnmt3b and 
to determine potential direct links between altered metabolism and OA induction or acceleration. For the 
purpose of  this study, we investigated if  overall cellular metabolism was altered in Dnmt3b LOF cells by 
analysis of  mitochondrial function. We found that mitochondrial respiration was increased, as were levels 
of  TCA cycle metabolites (succinate and fumarate) and NADH (generated by the TCA cycle and fed into 
the oxidative phosphorylation pathway). While it is known that chondrocytes primarily utilize glycolysis 
for energy production, it has been shown via NMR studies that terminal hypertrophic cells rely more on 
oxidative phosphorylation than resting growth plate chondrocytes (48). Since we have shown that Dnmt3b 
LOF chondrocytes express higher levels of  catabolic genes, including hypertrophic chondrocyte markers, 
this may be one explanation for why mitochondrial respiration appears to increase in these cells.
In conclusion, this potentially novel body of  research has established that Dnmt3b-mediated mecha-
nisms are important in maintaining postnatal cartilage homeostasis. Our findings show that inflammatory 
signals may play a role in decreasing Dnmt3b levels, which then leads to the disruption of  a number of  
cellular pathways including those involved in metabolic processes. Future studies will involve deciphering 
what specific metabolic pathways are disrupted in a Dnmt3b LOF scenario and if  direct modulation of  such 
pathways can negatively affect chondrocyte homeostasis that may lead to an OA phenotype. Interestingly, 
succinate levels were found to be elevated in Dnmt3b LOF cells and recent reports have shown that suc-
cinate itself  is an inflammatory signal that can induce IL-1β (49). It remains to be determined whether or 
not a vicious cycle may exist in OA chondrocytes whereby inflammation can modulate metabolic processes 
via downregulation of  Dnmt3b, thereby leading to increased production of  metabolic intermediates, such 
as succinate, which may then further enhance the inflammatory process. Overall, these studies will open 
up new avenues of  research with respect to exploring alternative therapeutic strategies to treat OA. Such 
approaches may involve development of  approaches to prevent loss of  Dnmt3b activity in the OA joint or 
target intermediates of  specific metabolic pathways that are regulated by this DNMT.
Methods
Human cartilage tissue. Two separate IRB-approved protocols were executed at the University of  Rochester 
to collect articular cartilage from normal, OA, and injured joints. Normal cartilage was collected from 
amputation patients (talus or knee, n = 11) and OA cartilage was harvested from total knee arthroplasty 
patients (n = 57). Injured cartilage, debrided from patients that underwent arthroscopic knee surgery to 
treat a recent meniscal injury (within 1 month, n = 14) was collected. At harvest, tissues were immediately 
fixed in 10% neutral buffered formalin and processed for embedding in paraffin. After facing the cartilage 
blocks on a microtome, between 1 and 4 biopsy punches were recovered from each block (1 mm diameter, 
3 mm deep) and transferred to a receiver block to create a tissue microarray containing 176 biopsies. PACs 
were also isolated from human knee articular cartilage tissue obtained from surgeons at Washington Uni-
versity Department of  Orthopaedic Surgery following total knee replacement surgery.
Transgenic mice. All mouse strains including Agc1CreERT2 (28), Col2a1Cre (50), Dnmt3bfl/fl (51), Rosa-
tomato (mT/mG) (52), and Rosa-rtTAfl/fl (53) have been previously described. Dnmt3bfl/fl mice were 
generated by En Li (Novartis) and were obtained from the Mutant Mouse Regional Resource Cen-
ter supported by the NIH. The Agc1CreERT2 mouse line was a gift from the laboratory of  Benoit de 
Crombrugghe (MD Anderson Cancer Center). The Col2a1Cre (catalog 003554), Rosa-tomato (mT/mG) 
(catalog 007576), and Rosa-rtTAfl/fl (catalog 006965) were purchased from the Jackson Laboratory. The 
efficiency of  the Agc1CreERT2 driver line in targeting chondrocytes of  knee joint articular cartilage was 
confirmed by generation of  Agc1CreERT2; Rosa-tomato (mT/mG) mice and analysis of  knee joint tissue 
sections by fluorescence microscopy. Agc1Cre; Dnmt3bfl/fl (Dnmt3bAgc1ER) mice were viable, fertile, and 
produced in expected Mendelian ratios. Tamoxifen (1 mg/10 g body weight/day) was delivered i.p. to 
all Dnmt3bAgc1ER mice and Cre+ littermate controls for 5 continuous days starting at 2 months of  age to 
permanently delete the Dnmt3b gene in adult cartilage tissue. Western blot analysis of  proteins extracted 
from articular cartilage of  3-month-old Dnmt3bAgc1ER or control mice was carried out to confirm Dnmt3b 
knockdown in the conditional knockout mice following tamoxifen injection. Knee joints from Dnmt3b 
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conditional knockout and Cre+ littermate control mice were harvested at 5 and 8 months of  age for 
histological and microCT analyses.
For production of  Dnmt3b GOF mice, a construct was generated by cloning full-length Flag-tagged murine 
Dnmt3b cDNA into the pBI-3 vector (54). The pBI-3 vector contains an rtTA promoter binding site upstream 
of Dnmt3b. Upon recombination, Dnmt3b is expressed with addition of  Dox. Thus, the model provides both 
cell-specific and temporal regulation of  Dnmt3b overexpression (Supplemental Figure 13). Dnmt3b-transgenic 
mice (Dnmt3b-tg) were subsequently generated by Cyagen Biosciences Inc. We obtained 68 Dnmt3b-tg mice, 
7 of  which were founder mice. Dnmt3b-tg mice were crossed with Col2a1Cre; Rosa-rtTAfl/+ mice to generate 
Dnmt3b GOF mice. These mice were viable, fertile, and produced in expected Mendelian ratios. The effi-
ciency of  the Col2a1-Cre driver line in targeting chondrocytes of  articular cartilage was confirmed by analysis 
of  knee joint tissue sections of  Col2a1Cre; Rosa-rtTAfl/+; H2BGFP mice by fluorescence microscopy. DOX (2.5 
mg/kg body weight) was administrated i.p. to 10-week-old male Dnmt3b GOF mice and littermate controls 1 
day prior to the MLI. DOX injections continued twice per week following MLI surgery for 8 or 12 weeks, at 
which point mice were sacrificed and knee joint specimens harvested for downstream histological analyses.
Murine knee joint analysis. Murine hind limbs were harvested, followed by removal of  skin and soft tissues 
before fixation in 10% neutral-buffered formalin for 3 days and decalcification in 14% EDTA for 7 days. 
Limbs were then processed, embedded in paraffin, and sectioned (5 μm). Alcian blue hematoxylin/orange G 
(ABH/OG) staining was performed to analyze knee joint tissue architecture and proteoglycan localization. 
Quantitative histomorphometry was performed on ABH/OG–stained sections (3 slides per mice) using the 
Osteomeasure Analysis System (Osteometrics). The tide mark was used to differentiate between unminer-
alized and mineralized articular cartilages. Joint pathology was also quantified using the OARSI scoring 
system (55). Briefly, sagittal sections obtained every 80 μm across the medial femorotibial joint were used 
to determine the maximal scores. For each group, 5 mice were analyzed, and 13–16 slides were examined 
by 2 blinded scorers. IHC was performed on sections using traditional antigen retrieval and colorimetric 
development methodologies. Briefly, paraffin slides were baked at 60°C overnight and after re-equilibration 
to room temperature, slides were deparaffinized through 3 changes in xylene, 100% ethanol, 95% ethanol, 
1 change in 70% ethanol, and final rehydration in distilled water. Heat-induced antigen retrieval was per-
formed with citric acid buffer (pH 6.0). Rabbit anti-mouse antibodies against COL2A1 (Thermo Fisher Sci-
entific, catalog MS235-P, 1:1,000), DNMT3A (LSBio, catalog LS-B7240, 1:1,000) and DNMT3B (LSBio, 
catalog LS-C111224, 1:1,000) were used. Impact NovaRed (Vector Laboratories, catalog SK-4805) was used 
for peroxidase substrate reaction. Counterstaining was performed using hematoxylin.
MicroCT analyses were performed on 2-, 4-, 6-, and 8-month-old mouse knee joints prior to decalcifica-
tion using a VivaCT 40 scanner. Briefly, the tibia was scanned from the knee to the connection at the fibula 
using a protocol consisting of  high-resolution (10.5 μm) x-ray energy settings of  55 kVp and 145 μA and 
300 ms integration time. Parameters of  subchondral bone volume, bone mineral density, and bone connec-
tive density were measured as previously described using the Scanco analysis software (56).
PAC isolation and culture. Articular cartilage was isolated from the knee joints of  3-month-old 
 Dnmt3bfl/fl mutant mice as previously described, with modifications (57). Briefly, articular cartilage was 
excised from femoral condyles and tibial plateaus with a scalpel and placed in 1× PBS. Cartilage frag-
ments were digested using 3 mg/ml collagenase D in 10 ml high glucose DMEM (Invitrogen, catalog 
11965-092) for 12 hours at 37°C. Murine articular chondrocyte cell suspensions were filtered through 
0.4-μm filters and seeded at a density of  500,000 cells/well in 6-well tissue culture plates in high-glucose 
DMEM supplemented with 10% FBS (Atlanta Biologicals, catalog EF-0050) and 1% penicillin/strepto-
mycin (Life Technologies, catalog 15140-122).
Full-thickness sections of  human articular cartilage were removed from the femoral condyles and tib-
ial plateaus of  specimens obtained following total knee replacement surgery, diced into 2-mm cubes, and 
digested in sterile spinner flasks for 90 minutes at 37°C in pronase digestion buffer (DMEM/F12 [Thermo 
Fisher Scientific, catalog 11320]; 5% FBS [Atlanta Biologicals, catalog EF-0050], 2% penicillin/strepto-
mycin [Thermo Fisher Scientific, catalog 15140122], and 0.4% pronase [Roche, catalog 11459643001]). 
Following washes in HBSS (Thermo Fisher Scientific, catalog 14025092), tissue was further digested in col-
lagenase digestion buffer at 37°C (DMEM/F12; 5% FBS; 2% penicillin/streptomycin; 0.035% collagenase 
P [Roche, catalog 11213865001]) for 14 to 16 hours. Cells were collected, filtered through 70-μm cell strain-
ers (VWR, catalog 10199-656), and plated at a density of  100,000 cells/cm2. After 24 hours, chondrocytes 
were treated with IL-1β (10 ng/ml; R&D Systems, catalog 201-LB) for 48 hours.
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Next-generation RNA-Seq and data analysis. PACs were isolated from Dnmt3bfl/fl mice and treated with 
either Adeno-Cre or Adeno-GFP (MOI = 100) for 72 hours. Total RNA was collected using the AllPrep 
DNA/RNA Mini Kit (Qiagen, catalog 80204). Total RNA concentration was determined with the Nano-
Drop 1000 spectrophotometer and RNA quality was assessed with the Agilent Bioanalyzer. The TruSeq 
RNA Sample Preparation Kit V2 (Illumina) was used for next-generation sequencing library construc-
tion (as per the manufacturer’s protocol) at the Genomics Research Center (GRC) at the University of  
Rochester Medical Center (URMC). Briefly, mRNA was purified from 100 ng total RNA with oligo-dT 
magnetic beads and fragmented. First-strand cDNA synthesis was performed with random hexamer prim-
ing followed by second-strand cDNA synthesis. End repair and 3′ adenylation was then performed on the 
double-stranded cDNA. Illumina adaptors were ligated to both ends of  the cDNA, purified by gel elec-
trophoresis, and amplified with PCR primers specific for the adaptor sequences to generate amplicons of  
approximately 200–500 bp in size. The amplified libraries were hybridized to the Illumina single-end flow 
cell and amplified using the cBot (Illumina) at a concentration of  8 pM per lane. Single-end reads of  100 
nt were generated for each sample and aligned to the organism-specific reference genome. Sequence reads 
were submitted to NCBI Gene Expression Omnibus (GEO GSE85148). Raw reads generated from the Illu-
mina HiSeq2500 sequencer were demultiplexed using configurebcl2fastq.pl version 1.8.4. Low-complexity 
reads and vector contamination were removed using sequence cleaner (“seqclean”) and the NCBI univec 
database, respectively. The FASTX toolkit (fastq_quality_trimmer) was applied to remove bases with qual-
ity scores below Q = 13 from the end of  each read. Processed reads were then mapped to the UCSC Mus 
musculus reference genome (mm10) with SHRiMP version 2.2.3 and differential expression analysis was 
performed using Cufflinks version 2.0.2: specifically, cuffdiff2 and usage of  the general transfer format 
(GTF) annotation file for the given reference genome. Heatmaps of  sample-to-sample distances using the 
rlog-transformed values, MA plots of  expression changes, and heatmaps of  significantly expressed genes 
were analyzed by DEseq2 package using R/Bioconductor platform (58). Network analysis of  differentially 
expressed genes was generated by the GeneMania tool (http://genemania.org/). Significantly differentially 
expressed genes were further analyzed for statistically enriched pathways using IPA (Ingenuity Systems, 
http://www.ingenuity.com) and categorized for biological function using DAVID (Functional Annotation 
Bioinformatics, http://david.abcc.ncifcrf.gov/).
Whole-genome bisulfite sequencing and data analysis. Following treatment of  murine articular chondrocytes 
(isolated from Dnmt3bfl/fl mice), with either Adeno-Cre or Adeno-GFP (MOI = 100) for 72 hours, genomic 
DNA was isolated using the AllPrep DNA/RNA Mini Kit. Genomic DNA was quantified using the Qubit 
fluorometer (Life Technologies) and DNA integrity was determined using the TapeStation with genomics 
DNA tape reagents (Agilent). Methylation libraries were generated with Epicentre’s EpiGnome Methyl-
Seq Kit in collaboration with the GRC at the URMC. Briefly, bisulfite conversion was carried out on 100 
ng of  genomic DNA using Zymo EZ DNA Methylation Gold as per the manufacturer’s recommenda-
tions (Zymo Research) and conversion efficiency was determined with the Bioanalyzer 2100 (Agilent). 
Single-stranded cDNA was generated and tagged from bisulfite-converted DNA using random hexamers 
containing a 5′ tag followed by terminal tagging to mark the 3′ end of  the DNA. Illumina-specific adaptors 
were added during PCR amplification. DNA libraries were purified with AmpureXP beads and quantified 
with the Bioanalyzer 2100 and Qubit fluorometer. The amplified libraries were hybridized to the Illumina 
paired-end flow cell and amplified using the cBot at a concentration of  8 pM per lane. Pair end reads of  
100 nt were generated for each sample and aligned to the organism-specific reference genome. Sequences 
reads were also submitted to the NCBI Gene Expression Omnibus (GEO GSE85148). Raw reads gener-
ated from the Illumina HiSeq2500 sequencer were demultiplexed using configurebcl2fastq.pl version 1.8.4. 
Pre-processing of  the data was be performed using Trimmomatic-0.32 for stringent adapter removal and 
quality filtering. Alignment of  the processed read data to the NCBI build 37.2 of  the Mus musculus genome 
was then performed using Bismark version 0.9.0, which made use of  bowtie version 2.1.0 and samtools 
version 0.1.19. Methylation extraction was also performed using Bismark version 0.9.0 with the following 
parameters: “--cutoff  5 --ignore 3 --ignore_r2 3”. A Python program was written to combine the meth-
ylation information in the form of  an average percentage methylation for each locus that was called by 
Bismark for all 3 replicates within a group and to convert to the format that DSS package (59) required for 
differential methylation analysis. The DMRs were chosen using cutoffs with delta methylation level as 0.1, 
P value as 0.01, and minimum length as 200 bp (the average size of  DMRs was 560 bp, data not shown). 
A customized Python script was used to assign methylation values to the 500-bp windows among genome, 
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and methylation differences between Dnmt3b LOF and control group at genome back-
ground or DMRs were plotted using ggplot2 package (http://ggplot2.org/). DMRs 
were further annotated to genomic regions based on refGene annotation from UCSC 
Genome Browser (http://genome.ucsc.edu/) using customized scripts. Motif  search 
within DMRs was done using Homer software (60) with default parameters.
Metabolite analysis and mitochondria stress test. Proteins were isolated from PACs 
and 10-μl samples were injected into an LC-20 AD HPLC system (Shimadzu), which 
was coupled to a triple-quadrupole mass spectrometer (Thermo Fisher Scientific). 
Metabolites were analyzed by LC-MS/MS as previously described (61). Briefly, artic-
ular chondrocytes were plated in XF96 plates at 50,000 cells per well with XF Assay 
Medium Modified DMEM (Seahorse, catalog 101022-100). Oligomycin and FCCP 
(Seahorse Stress Kit) were prepared in XF assay medium at a final concentration of  5 
μM and 1 μM, respectively, and were injected during the measurements. At the end of  
the assays, protein concentrations were measured for normalization.
Dnmt3b promoter luciferase assay. ATDC-5 cells were purchased from Sigma-
Aldrich (catalog 99072806) and were transfected with a pGL4 luciferase plasmid con-
taining cDNA encoding 1 kb of  the murine Dnmt3b promoter using X-tremeGENE 
transfection reagents (Roche, catalog 06366236001). A Dnmt3b promoter construct 
containing mutations in the predicted NF-κB binding site was also transfected into 
an additional set of  ATDC-5 cells. All transfected cells were then treated with IL-1β 
(1 ng/ml) for 24 hours before performing the luciferase assay.
ChIP assay. ATDC-5 cells (1 × 107) were harvested for ChIP assays following the 
manufacturer’s protocol (Cell Signaling Technology, catalog 9003). Briefly, cells were 
fixed with formaldehyde and chromatin was fragmented by micrococcal nuclease 
to 200 to 900 bp. ChIPs were performed using an anti–NF-κB1 antibody (Cell Sig-
naling Technology, catalog 13586, 1:50) while histone H3 and IgG antibodies were 
used as positive and negative controls, respectively. After reversal of  protein-DNA 
crosslinking, the enrichment of  the Dnmt3b DNA fragment during immunoprecipita-
tion was analyzed by standard PCR and real-time qPCR. Dnmt3b primer sequences 
used for PCR were: Forward, 5′-CTGGTCATCTAGGAGGGTGA-3′; and Reverse, 
5′-CGGGCGAGGGAGATTTG-3′.
TET activity assay. Nuclear extracts were prepared from the Dnmt3b LOF chon-
drocytes or WT control chondrocytes using a cell nuclear extraction preparation kit 
(Active Motif, catalog 40010). These nuclear extracts (containing 5 μg protein) were then used to assess 
total TET activity according to the manufacturer’s instructions (Abcam).
Real-time qPCR and Western blot. RNA was isolated from ATDC-5 chondrocytes or PACs using an 
RNeasy Mini kit (Qiagen, catalog 74134). cDNA synthesis and real-time RT-PCR was performed accord-
ing to the manufacturers’ instructions. Primer sequences for Col2a1, Runx2, Mmp13, Col10a1, Dnmt1, 
Dnmt3a, Dnmt3b, Tet1, Tet2, Tet3, and β-actin are shown in Table 3. Western blot analyses were conducted 
on the protein of  lysates from either ATDC-5 cells or primary (murine or human) articular chondrocytes. 
The following primary antibodies were used: p-Smad1/5 (Cell Signaling Technology, catalog 9516, 1:500), 
p-Smad3 (Abcam, catalog ab52903, 1:1,000), Smad1/5 (Cell Signaling Technology, catalog 6944, 1:1,000), 
Smad3 (Abcam, catalog ab40854, 1:1,000), DNMT3A (LSBio, catalog LS-B7240, 1:1,000), DNMT3B 
(LSBio, catalog LS-C111224, 1:1,000) and β-actin (Sigma-Aldrich, catalog 2228, 1:2,000).
Cell proliferation and cell death detection. BMP-2–treated PACs isolated from 2-month-old WT (C57BL/6) 
mice were treated with vehicle or rotenone and antimycin A for 48 hours. Cell proliferation and cell death 
were detected by a Roche Proliferation ELISA Kit (Roche, catalog 11647229001) and Cell Death Detection 
ELISA Kit (Roche, catalog 11774425001).
Succinate concentration assay. PACs isolated from 2-month-old WT mice were treated with vehicle or 
diethylsuccinate (1 mM, Sigma-Aldrich, catalog 112402) for 48 hours. Intracellular succinate concentration 
was measured using the succinate colorimetric assay kit following the manufacturer’s instructions (Sigma-
Aldrich, catalog MAK184-1KT).
Statistics. Data (in vitro experiments and histomorphometry) are presented as mean ± SD. The compar-
isons for OARSI scores, bone mass, and microarchitecture among different groups were performed using 
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multifactorial ANOVA. When ANOVA testing indicated overall significance of  main effects and without 
interaction between them, the difference between individual time points and sites was assessed by post hoc 
tests. The level of  significance was set at P less than 0.05. Statistical tests for RNA-Seq and methylC-Seq 
data analysis were performed using the R environment (http://www.r-project.org/).
Study approval. Human cartilage tissue used for IHC analysis was harvested following the IRB-approved 
protocols of  University of  Rochester (IRB ID RSRB00042321 and ID RSRB00014518). Human knee artic-
ular chondrocyte isolation was approved by the Washington University Human Research Protection Office 
(IRB ID 201104119). Patients provided written informed consent prior to their participation in the study. 
All studies involving mice were approved by the University of  Rochester Committee on Animal Resources.
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